BEAUVERICIN
- CAS No.
- 26048-05-5
- Chemical Name:
- BEAUVERICIN
- Synonyms
- nivea;Beauveria bassiana (Balsamo) Vuillemin;bovein;bassiana;beauverin;Beauveria;BEAUVERICIN;BEAUVERFICIN;Beauveria sp.;Beauvericin 97%
- CBNumber:
- CB4345714
- Molecular Formula:
- C45H57N3O9
- Molecular Weight:
- 783.95
- MDL Number:
- MFCD30541349
- MOL File:
- 26048-05-5.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| Beauvericin ≥97% (HPLC) | B7510 | 5mg | $248 |
| Beauvericin VETRANAL?, analytical standard | 37012 | 100μg | $895 |
| Beauvericin ≥95% | 11426 | 1mg | $39 |
| Beauvericin ≥95% | 11426 | 5mg | $164 |
| Beauvericin ≥95% | 11426 | 10mg | $308 |
| More product size | |||
| Melting point | 93-94℃ |
|---|---|
| Boiling point | 975.6±65.0 °C(Predicted) |
| Density | 1.126±0.06 g/cm3(Predicted) |
| storage temp. | 2-8°C |
| solubility | Soluble in DMSO (30 mg/ml) |
| pka | -1.02±0.70(Predicted) |
| form | Solid |
| color | White |
| Stability | Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months. |
| InChIKey | GYSCAQFHASJXRS-ABKJGVMTSA-N |
| SMILES | C(C1C=CC=CC=1)C1C(OC(C(N(C(C(OC(C(C)C)C(=O)N(C)C(CC2C=CC=CC=2)C(=O)OC(C(C)C)C(=O)N1C)=O)CC1C=CC=CC=1)C)=O)C(C)C)=O |
| EWG's Food Scores | 1 |
| FDA UNII | 26S048LS2R |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H319-H335-H315-H302+H312+H332 |
| Precautionary statements | P280-P261-P271 |
| WGK Germany | 3 |
| HS Code | 29419090 |
BEAUVERICIN price More Price(54)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | B7510 | Beauvericin ≥97% (HPLC) | 26048-05-5 | 5mg | $248 | 2026-04-30 | Buy |
| Sigma-Aldrich | 37012 | Beauvericin VETRANAL?, analytical standard | 26048-05-5 | 100μg | $895 | 2022-05-15 | Buy |
| Cayman Chemical | 11426 | Beauvericin ≥95% | 26048-05-5 | 1mg | $39 | 2026-04-30 | Buy |
| Cayman Chemical | 11426 | Beauvericin ≥95% | 26048-05-5 | 5mg | $164 | 2026-04-30 | Buy |
| Cayman Chemical | 11426 | Beauvericin ≥95% | 26048-05-5 | 10mg | $308 | 2026-04-30 | Buy |
BEAUVERICIN Chemical Properties,Uses,Production
Description
Beauvericin (CAS 26048-05-5) induces apoptosis in A549 cancer cells.1 Disrupts mitochondrial volume regulation.2 Antifungal activity acting via inhibition of both multidrug efflux and TORC1 kinase.3 Crosses the blood-brain barrier in mice.4 Inhibits HIV-1 integrase.5
Chemical Properties
White powder
Uses
Beauvericin is a cyclic depsipeptide isolated from several fungal genera, notably Beauveria and Fusarium, first reported in 1969. Beauvericin exhibits broad antifungal, antibacterial, antiprotozoan and insecticidal activities. At the molecular level, beauvericin exhibits ionophoric properties, and inhibits acyl-CoA:cholesterol acyltransferase activity. Beauvericin induces apoptosis by elevating intracellular calcium levels.
Uses
Toxic depsipeptide with antibiotic and insecticidal effects.Beauvericin is a toxic depsipeptide with antibiotic and insecticidal effects.
Definition
ChEBI: A trimeric cyclodepsipeptide composed from alternating methylphenylalanyl and hydroxyvaleryl residues.
in vivo
Beauvericin (5 mg/kg; i.p.; after the first dosing cycle, observe for two days and continue the second dosing cycle) reduces tumor volume and increases necrosis in allogeneic transplant model mice[3]. Beauvericin (3, 5, 7 mg/kg; i.p.; once a week for three weeks) can significantly inhibit the growth of H22 allogeneic transplant model mice and increase the levels of TNF-α and IL-2 in mice[5].
| Animal Model: | BALB/c mice injected subcutaneously with mouse CT-26 colon cancer cells on the right side[3] |
| Dosage: | 5 mg/kg |
| Administration: | ntraperitoneal injection (i.p.);The drug was administered on the third day after the injection of colon cancer cells and continued once a day for five days, then stopped for two days of observation, and continued on the tenth day after the injection of colon cancer cells, and continued once a day for four days. |
| Result: | Reduced the average tumor volume by 52.8 % and the average tumor weight by 60 %. |
| Animal Model: | Human cervical cancer KB-3-1 xenograft mouse model[3] |
| Dosage: | 5 mg/kg |
| Administration: | Intraperitoneal injection (i.p.); The drug was administered once a day starting on the fifth day after cervical cancer injection for five days, followed by two days of observation. The drug was administered once a day starting on the twelfth day after cervical cancer cell injection for four days. |
| Result: | Reduced the average tumor volume by 31.3 % and the average tumor weight by 31.2 %. |
IC 50
ACAT
References
[1] CHIEN-LIN LU. Beauvericin-induced cell apoptosis through the mitogen-activated protein kinase pathway in human nonsmall cell lung cancer A549 cells.[J]. Journal of Toxicological Sciences, 2016, 41 3: 429-437. DOI:10.2131/jts.41.429
[2] ANTON A. TONSHIN . The Fusarium mycotoxins enniatins and beauvericin cause mitochondrial dysfunction by affecting the mitochondrial volume regulation, oxidative phosphorylation and ion homeostasis[J]. Toxicology, 2010, 276 1: Pages 49-57. DOI:10.1016/j.tox.2010.07.001
[3] TANVI SHEKHAR-GUTURJA. Dual action antifungal small molecule modulates multidrug efflux and TOR signaling[J]. Nature chemical biology, 2016, 12 10: 867-875. DOI:10.1038/nchembio.2165
[4] LIEN TAEVERNIER . Blood-brain barrier transport kinetics of the cyclic depsipeptide mycotoxins beauvericin and enniatins[J]. Toxicology letters, 2016, 258: Pages 175-184. DOI:10.1016/j.toxlet.2016.06.1741
[5] CHA-GYUN SHIN. Beauvericin and enniatins H, I and MK1688 are new potent inhibitors of human immunodeficiency virus type-1 integrase[J]. Journal of Antibiotics, 2009, 62 12: 687-690. DOI:10.1038/ja.2009.102
BEAUVERICIN Preparation Products And Raw materials
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Hebei Zhuanglai Chemical Trading Co.,Ltd | 13343047651 | admin@zlchemi.com | China | 3689 | 58 |
| Hebei Zhuanglai Chemical Trading Co Ltd | +86-16264648883 | niki@zlchemi.com | China | 7239 | 58 |
| Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 | info@tianfuchem.com | China | 21531 | 55 |
| Chengdu Biopurify Phytochemicals Ltd. | +86-28-82633860; +86-18080483897 | sales@biopurify.com | China | 4616 | 58 |
| Shandong chuangyingchemical Co., Ltd. | 18853181302 | sale@chuangyingchem.com | CHINA | 5898 | 58 |
| career henan chemical co | +86-0371-86658258 | factory@coreychem.com | China | 29780 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| Hefei Hangang Pharmaceutical Technology Co., Ltd. | +8618062405514 | ada@ipurechemical.com | China | 10224 | 58 |
| Longyan Tianhua Biological Technology Co., Ltd | 0086 18039857276 18039857276 | CHINA | 2777 | 58 | |
| Hefei TNJ Chemical Industry Co.,Ltd. | +86-0551-65418671 +86-189 4982 3763 | sales@tnjchem.com | China | 34526 | 58 |
View Lastest Price from BEAUVERICIN manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-27 | Beauvericin
26048-05-5
|
$64.00 | ≥98% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2026-07-27 | Beauvericin
26048-05-5
|
$64.00 | ≥98% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2025-05-23 | BEAUVERICIN
26048-05-5
|
$50.00 | 1kg | 99 | 5000 | Hebei Zhuanglai Chemical Trading Co Ltd |
-

- Beauvericin
26048-05-5
- $64.00
- ≥98%
- TargetMol Chemicals Inc.
-

- Beauvericin
26048-05-5
- $64.00
- ≥98%
- TargetMol Chemicals Inc.
-

- BEAUVERICIN
26048-05-5
- $50.00
- 99
- Hebei Zhuanglai Chemical Trading Co Ltd
26048-05-5(BEAUVERICIN)Related Search:
1of4





